ESC 365 - Are triglycerides and triglyceride-rich lipoproteins still relevant?

ESC Professional Premium Access

Are triglycerides and triglyceride-rich lipoproteins still relevant?

Session: Targeting the spectrum of atherogenic lipoproteins: what to do and how to do it

Topic: Risk Factors and Prevention

Speaker: Professor E. Stroes (Amsterdam, NL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))

39 presentations

0 follower

4 more presentations in this session

What are the unmet needs for lipid-lowering in the population?

Speaker: Professor M. Banach (Lodz, PL)

New therapies to lower LDL-C: how to choose?

Speaker: Professor L. Tokgozoglu (Ankara, TR)

Why measure Lp(a) and what to do about it?

Speaker: Professor F. Kronenberg (Innsbruck, AT)

Targeting the spectrum of atherogenic lipoproteins: what to do and how to do it - discussion

Access the full session

Targeting the spectrum of atherogenic lipoproteins: what to do and how to do it

Speakers: Professor E. Stroes, Professor M. Banach, Professor L. Tokgozoglu, Professor F. Kronenberg

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources